327 results on '"Zhukova, Nataliya"'
Search Results
52. A reaction for the synthesis of benzimidazoles and 1 H-imidazo[4,5- b]pyridines via a novel rearrangement of quinoxalinones and their aza-analogues when exposed to 1,2-arylenediamines
53. A Common Molecular Mechanism Underlies Two Phenotypically Distinct 17p13.1 Microdeletion Syndromes
54. Discovery of the First in Class 9-N-Berberine Derivative as Hypoglycemic Agent with Extra-Strong Action
55. Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach
56. Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine.
57. 9-N-n-alkyl Berberine Derivatives: Hypoglycemic Activity Evaluation.
58. Context Aware Data Collection Systems for Cyber-Physical Systems
59. Triple intraventricular chemotherapy for treatment of relapsed choroid plexus carcinoma
60. Recent Developments Towards Synthesis of (Het)arylbenzimidazoles
61. Progress in Quinoxaline Synthesis (Part 2)
62. Progress in Quinoxaline Synthesis (Part 1)
63. Mechanistic Insights for Acid‐catalyzed Rearrangement of Quinoxalin‐2‐one with Diamine and Enamine
64. Ongoing issues with the management of children with Constitutional Mismatch Repair Deficiency syndrome
65. LGG-42. BEVACIZUMAB-ASSOCIATED SECONDARY AMENORRHEA AND PREMATURE OVARIAN FAILURE IN ADOLESCENT FEMALE PATIENTS WITH LOW-GRADE CNS DISEASE
66. ATRT-22. HIGH-THROUGHPUT DRUG SCREENING OF FDA-APPROVED CANCER DRUGS REVEALS POTENTIAL THERAPEUTIC APPROACHES FOR ATYPICAL TERATOID RHABDOID TUMOUR
67. DDEL-17. TRIPLE INTRAVENTRICULAR CHEMOTHERAPY FOR TREATMENT OF RELAPSED CHOROID PLEXUS CARCINOMA
68. Bornyl Derivatives of p-(Benzyloxy)Phenylpropionic Acid: In Vivo Evaluation of Antidiabetic Activity
69. Hypoglycemic activity study of novel bornyl derivatives of p-(benzyloxy)phenylpropionic acid
70. Environmentally friendly and efficient method for the synthesis of the newα,α′‐diimine ligands with benzimidazole moiety
71. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
72. Acid-Catalyzed Rearrangement of 3-Cyanoquinoxalin-2(1H)-ones When Exposed to 1,2-Diaminobenzenes: Synthesis of 2,2′-Bibenzimidazoles
73. 3‐(α‐Chlorobenzyl)quinoxalin‐2(1 H )‐ones as Versatile Reagents for the Synthesis of 3‐Benzylquinoxalin‐2(1 H )‐ones and Thiazolo[3,4‐ a ]quinoxalin‐4(5 H )‐ones
74. 2,3-(Dibenzimidazol-2-yl)quinoxalines: Unexpected Dynamical Effect on Steady-State Electronic Absorption Spectra
75. Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.
76. Chapter 1 - Recent Advances in the Synthesis of Benzimidazol-2-ones via Rearrangements
77. Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue
78. Environmentally friendly and efficient method for the synthesis of the new α,α′‐diimine ligands with benzimidazole moiety.
79. Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma
80. One-Pot Synthesis of 7-(Benzimidazol-2-yl)thioxolumazine and -lumazine Derivatives via H2SO4-Catalyzed Rearrangement of Quinoxalinones When Exposed to 5,6-Diamino-2-mercapto- and 2,5,6-Triaminopyrimidin-4-ols
81. 'ЕЛЕГАНТНІСТЬ ЇЖАЧКА' МЮРІЕЛЬ БАРБЕРІ: МЕТАФІЗИКА ЧИ ПРОТОКУЛЬТУРА?
82. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
83. LGG-18. MOLECULAR ALTERATIONS PREDICT RESPONSE TO CHEMOTHERAPY AND OUTCOME OF PEDIATRIC LOW-GRADE GLIOMA
84. 3‐(α‐Chlorobenzyl)quinoxalin‐2(1H)‐ones as Versatile Reagents for the Synthesis of 3‐Benzylquinoxalin‐2(1H)‐ones and Thiazolo[3,4‐a]quinoxalin‐4(5H)‐ones.
85. Quinoxalinone–benzimidazole rearrangement: an efficient strategy for the synthesis of structurally diverse quinoline derivatives with benzimidazole moieties
86. Benzimidazolylquinoxalines: novel fluorophores with tuneable sensitivity to solvent effects
87. Aggregation and Solubilization Properties of System Based on Glycine-Calix[4]resorcinol and Sodium Dodecyl Sulfate in Aqueous Medium
88. PDCT-09. HYPERMUTATION AND NEOANTIGEN FORMATION IS DIAGNOSTIC AND PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT BRAIN TUMORS
89. Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
90. LG-66CLINICAL AND TREATMENT FACTORS DETERMINING LONG-TERM OUTCOMES FOR ADULT SURVIVORS OF CHILDHOOD LOW-GRADE GLIOMA: A POPULATION-BASED STUDY
91. HG-53HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA
92. LG-46INFERIOR OUTCOME AND POOR RESPONSE TO CONVENTIONAL THERAPIES IN PEDIATRIC LOW-GRADE GLIOMAS HARBORING THE BRAF V600E MUTATION
93. LG-58THERAPEUTIC IMPLICATIONS OF MOLECULAR BIOMARKERS IN INFANTS WITH PEDIATRIC LOW-GRADE GLIOMA
94. LG-68THE GENETIC AND CLINICAL LANDSCAPE IN PEDIATRIC LOW GRADE GLIOMA; PRELIMINARY RESULTS FROM PLGG TASKFORCE
95. HG-80ISSUES IN THE MANAGEMENT OF CHILDREN WITH BRAIN TUMORS AND BIALLELIC MISMATCH GENE REPAIR DEFICIENCY SYNDROME
96. Relationship of BRAF V600E and associated secondary mutations on survival rate and response to conventional therapies in childhood low-grade glioma.
97. Sa2045 Tumor Spectrum, Diagnostic Tools and Survival in Patients With Biallelic Mismatch Repair Gene Deficiency (BMMRD) Syndrome: Report From the International BMMRD Consortium
98. Chapter 1 - Progress in Quinoxaline Synthesis (Part 2)
99. Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low‐grade glioma.
100. One-Pot Synthesis of 7‑(Benzimidazol-2-yl)thioxolumazine and -lumazine Derivatives via H2SO4‑Catalyzed Rearrangement of Quinoxalinones When Exposed to 5,6-Diamino-2-mercapto- and 2,5,6-Triaminopyrimidin-4-ols.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.